Authors:
Kovac, C
Chie, L
Morin, J
Friedman, FK
Robinson, R
Chung, DL
Kanovsky, M
Flom, J
Brandt-Rauf, PW
Yamaizumi, Z
Michl, J
Pincus, MR
Citation: C. Kovac et al., Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation, CANC CHEMOT, 48(1), 2001, pp. 9-14
Authors:
Kanovsky, M
Raffo, A
Drew, L
Rosal, R
Do, T
Friedman, FK
Rubinstein, P
Visser, J
Robinson, R
Brandt-Rauf, PW
Michl, J
Fine, RL
Pincus, MR
Citation: M. Kanovsky et al., Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells, P NAS US, 98(22), 2001, pp. 12438-12443
Authors:
Ranginwale, M
Smith, S
Flom, J
Chie, L
Kanovsky, M
Chung, D
Friedman, FK
Robinson, RC
Brandt-Rauf, PW
Yamaizumi, Z
Michl, J
Pincus, MR
Citation: M. Ranginwale et al., Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes, EXP CELL RE, 269(1), 2001, pp. 162-169
Authors:
Sapone, A
Peters, JM
Sakai, S
Tomita, S
Papiha, SS
Dai, RK
Friedman, FK
Gonzalez, FJ
Citation: A. Sapone et al., The human peroxisome proliferator-activated receptor a gene: identification and functional characterization of two natural allelic variants, PHARMACOGEN, 10(4), 2000, pp. 321-333
Authors:
Pincus, MR
Brandt-Rauf, PW
Michl, J
Carty, RP
Friedman, FK
Citation: Mr. Pincus et al., ras-p21-induced cell transformation: Unique signal transduction pathways and implications for the design of new chemotherapeutic agents, CANCER INV, 18(1), 2000, pp. 39-50
Authors:
Chie, L
Amar, S
Kung, HF
Lin, MCM
Chen, H
Chung, DL
Adler, V
Ronai, Z
Friedman, FK
Robinson, RC
Kovac, C
Brandt-Rauf, PW
Yamaizumi, Z
Michl, J
Pincus, MR
Citation: L. Chie et al., Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway, CANC CHEMOT, 45(6), 2000, pp. 441-449
Authors:
Chen, JM
Rijhwani, K
Friedman, FK
Hyde, MJ
Pincus, MR
Citation: Jm. Chen et al., Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling, J PROTEIN C, 19(7), 2000, pp. 545-551
Authors:
Omata, Y
Dai, RK
Smith, SV
Robinson, RC
Friedman, FK
Citation: Y. Omata et al., Synthetic peptide mimics of a predicted topographical interaction surface:The cytochrome P4502B1 recognition domain for NADPH-cytochrome P450 reductase, J PROTEIN C, 19(1), 2000, pp. 23-32
Authors:
Smith, SV
Koley, AP
Dai, RK
Robinson, RC
Leong, H
Markowitz, A
Friedman, FK
Citation: Sv. Smith et al., Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: A CO flash photolysis study, BIOCHEM, 39(19), 2000, pp. 5731-5737
Authors:
Monaco, R
Friedman, FK
Hyde, MJ
Chen, JM
Manolatus, S
Adler, V
Ronai, Z
Koslosky, W
Pincus, MR
Citation: R. Monaco et al., Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics, J PROTEIN C, 18(8), 1999, pp. 859-866
Authors:
Chen, JM
Friedman, FK
Hyde, MJ
Monaco, R
Pincus, MR
Citation: Jm. Chen et al., Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS, J PROTEIN C, 18(8), 1999, pp. 867-874
Authors:
Chie, L
Chen, JM
Friedman, FK
Chung, DL
Amar, S
Michl, J
Yamaizumi, Z
Brandt-Rauf, PW
Pincus, MR
Citation: L. Chie et al., Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations, selective inhibition of oncogenic ras-p21, J PROTEIN C, 18(8), 1999, pp. 875-879
Authors:
Chie, L
Chen, JM
Friedman, FK
Chung, DL
Amar, S
Michl, J
Yamaizumi, Z
Brandt-Rauf, PW
Pincus, MR
Citation: L. Chie et al., Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain, J PROTEIN C, 18(8), 1999, pp. 881-884
Authors:
Wei, XX
Dai, RK
Zhai, SP
Thummel, KE
Friedman, FK
Vestal, RE
Citation: Xx. Wei et al., Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide, J PHARM EXP, 289(2), 1999, pp. 853-858